Consun Pharmaceutical Group financials at a glance

+ Portfolio

The revenue of Consun Pharmaceutical Group is reported as 2.645 billion Dollars in the fiscal year 2023. The earnings were 0.96 Dollars per share in 2023, which was 40.63 higher than 2020. And about 0.654 billion Dollars are reported as free cash flow in the financials of Consun Pharmaceutical Group 2023. Dividends of 0.32 Dollars per share were paid to shareholders of Consun Pharmaceutical Group stock SEHK:1681 in fiscal 2023.

HK$2.34B

Revenue

HK$0.90

Earnings Per Share

75.35%

Gross Margin %

HK$0.00M

Free Cash Flow

Revenue

2,339.65

Earnings Per Share

0.90

Gross Margin %

75.35

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2020	2019	2018	2017	2016	2015	2014	2013
Rev.	Revenue	N/A	HK$2.34B	HK$1.75B	HK$1.73B	HK$1.84B	HK$1.66B	HK$1.22B	HK$831.11M	HK$730.68M	HK$571.77M
GM %	Gross Margin %	75.48%	75.35%	75.40%	72.99%	75.08%	73.99%	74.46%	80.68%	78.25%	79.09%
OM	Operating Margin	31.55%	30.58%	31.39%	28.72%	35.54%	32.13%	32.57%	35.37%	32.23%	36.00%
EPS	Earnings Per Share	HK$0.92	HK$0.90	HK$0.64	HK$0.27	HK$0.53	HK$0.46	HK$0.32	HK$0.25	HK$0.21	HK$0.20
Div.	Dividends	N/A	HK$0.26	HK$0.23	HK$0.18	HK$0.17	HK$0.20	HK$0.04	HK$0.08	HK$0.07	HK$0.00
PR %	Payout Ratio %	0	28.89%	35.94%	66.67%	32.08%	43.48%	12.50%	32.00%	33.33%	0.00%
Sha.	Shares	N/AM	788.39M	799.83M	845.73M	855.39M	853.81M	954.27M	977.76M	990.47M	1,000M
OCF	Operating Cash Flow	N/A	HK$414.00M	HK$867.06M	HK$383.32M	HK$754.21M	HK$252.12M	HK$449.18M	HK$184.04M	HK$294.72M	HK$163.61M
FCF	Free Cash Flow	N/A	HK$362.41M	HK$818.36M	HK$203.57M	HK$560.86M	HK$197.15M	HK$424.15M	HK$166.76M	HK$273.75M	HK$99.52M
FCFS	Free Cash Flow Per Share	HK$1.05	HK$1.13	HK$1.00	HK$0.24	HK$0.66	HK$0.23	HK$0.40	HK$0.17	HK$0.27	HK$0.13

Consun Pharmaceutical Group financials at a glance

Financials

Discover